Candesartan Is Associated With Lower Amyloid Accumulation
Candesartan Is Associated With Lower Amyloid Accumulation
Consumers and health professionals are advised that the TGA is investigating the potential contamination of 'sartan' blood pressure medicines.
Update on the EDQM review of CEP applications for sartan substances (4 Feb 2019)